Florida, February 22, 2018:

    The Global Bioinformatics Market is expected to exceed more than US$ 16.0 Billion by 2022 at a CAGR of 21.1% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets for Global Bioinformatics Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Accelrys Inc., ID Business Solutions, Ltd., Affymetrix Inc., CLC bio A/S, Agilent Technologies Inc., GenoLogics Life Sciences Software, Inc., Life Technologies Corporation, and Illumina Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Browse Full Report: https://www.marketresearchengine.com/bioinformatics-market-report

    The Global Bioinformatics Market has been segmented as below:

    By Sector Analysis

    • Medical Biotechnology
    • Animal Biotechnology
    • Academics
    • Agricultural Biotechnology
    • Forensic Biotechnology
    • Environmental Biotechnology
    • Other Sectors

    By Product and Service Analysis

    • Knowledge Management Tools
    • Bioinformatics Services
    • Bioinformatics Platforms

    By Application Analysis

    • Genomics
    • Proteomics
    • Chemoinformatics and Drug Design
    • Transcriptomics
    • Molecular Phylogenetics
    • Metabolomics
    • Other Applications

    By Regional Analysis

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    This report provides:

    1) An overview of the global market for Bioinformatics and related technologies.

    2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2020.

    3) Identifications of new market opportunities and targeted promotional plans for Global Bioinformatics Market.

    4) Discussion of research and development, and the demand for new products and new applications.

    5) Comprehensive company profiles of major players in the industry.

    The major driving factors of Global Bioinformatics Market are as follows:

    • Increasing Biotechnology production in Emerging Markets
    • Private and government organizations initiatives are increasing
    • Growing adoption of bioinformatics tools in different sectors
    • Demand for nucleic acid and protein sequencing is growing
    • Cloud technology and nanopore sequencing technology

    The restraining factors of Global Bioinformatics Market are as follows:

    • Lack of Skilled Bioinformatics Professionals
    • No integration of data and no standard data formats
    • Need uniform formats
    • Organizinglarge Volumes of Data
    • Competition from in house progress and publically available tools is growing

    Buy Report from here: https://www.marketresearchengine.com/bioinformatics-market-report

    Table of Contents


    2 Research Methodology

    3 Executive Summary

    4 Premium Insights

    5 Market Overview

    6 Bioinformatics Market, By Sector

    7 Bioinformatics Market, By Products & Services

    8 Bioinformatics Market, By Application

    9 Bioinformatics Market, By Region

    10 Competitive Landscape

    11 Company Profiles

    11.1 Introduction

    11.2 Illumina, Inc.

    11.3 Thermo Fisher Scientific Inc.

    11.4 Qiagen N.V.

    11.5 Agilent Technologies

    11.6 Applied Biological Materials (ABM)

    11.7 Biomax Informatics Ag

    11.8 DNAnexus, Inc.

    11.9 ID Business Solutions Ltd.

    11.10 Perkinelmer, Inc.

    11.11 Waters Corporation

    Media Contact

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com

    Source: http://www.financeswire.com/bioinformatics-market-share-is-worth-us-16-billion-by-2022